Clinical Trial Update: A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major Depression [Phase 1]

View source ↗

Summary

This clinical trial update indicates SP-624 is being studied in Phase 1 to assess its effects on brain network analytics in healthy adults and adults with major…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SP-624 (SP-624)

Snippet

Sponsor: Sirtsei Pharmaceuticals, Inc. | Conditions: Major Depressive Disorder, Depression | Phase 1 | Status: RECRUITING